Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
- Age
- 1 Month – 6 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 36 (estimated)
- Sponsor
- The Hospital for Sick Children · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to evaluate the safety and explore the PK/PD of L-CIT supplementation in preterm infants to prevent the development of inflammatory pathways initiated by low levels of plasma CIT, specifically in preterm infants with post-surgical NEC and BPD±PH.
Loading trial locations…